UM
Residential Collegefalse
Status已發表Published
Tolerability of hypodermic injection of pegfilgrastin (PEG-G-CSF) in a phase I study
Zheng L.2; Xu N.2; Liu C.-T.2; Wang Y.2; Luo Z.2; Luo H.1
2008-09-15
Source PublicationChinese Journal of Evidence-Based Medicine
ISSN16722531
Volume8Issue:3Pages:155-158
AbstractObjective: To evaluate the safety and tolerance of pegfilgrastin (PEG-G-CSF) in Chinese healthy volunteers. Methods: Thirty healthy volunteers were randomly divided into five single-dose groups to receive PEG-GCSF 15, 30, 50, 60 or 75 μg/kg by hypodermic injection. The safety profile and tolerabil ity were evaluated by observing symptoms, vital signs, laboratory tests and electro cardiogram. Results: No serious adverse event was reported for any volunteer. Transient dizziness occurred in one person in the 50 μg/kg dose group, and mild dizziness and ostalgia was found in all six people in the 75 μg/kg dose group, of whom one experienced transient fever and two experienced mild diarrhea. No cl inically significant changes in laboratory tests and electrocardiogram were found during the follow-up period. Conclusions: The maximum tolerated dose of PEG-G-CSF injection in Chinese healthy volunteers is 60 μg/kg. Doses below 60 μg/kg can be well tolerated. The recommended dose for phase II cl inical trials is 60 μg/kgone, one dose for each cycle of chemotherapy. © 2008 Editorial Board of Chin J Evid-based Med.
KeywordPegfilgrastin (PEG-G-CSF) Safety Tolerance
URLView the original
Language英語English
Fulltext Access
Document TypeJournal article
CollectionUniversity of Macau
Affiliation1.Chongqing Fujin Biology and Medicine Company
2.West China Hospital of Sichuan University
Recommended Citation
GB/T 7714
Zheng L.,Xu N.,Liu C.-T.,et al. Tolerability of hypodermic injection of pegfilgrastin (PEG-G-CSF) in a phase I study[J]. Chinese Journal of Evidence-Based Medicine, 2008, 8(3), 155-158.
APA Zheng L.., Xu N.., Liu C.-T.., Wang Y.., Luo Z.., & Luo H. (2008). Tolerability of hypodermic injection of pegfilgrastin (PEG-G-CSF) in a phase I study. Chinese Journal of Evidence-Based Medicine, 8(3), 155-158.
MLA Zheng L.,et al."Tolerability of hypodermic injection of pegfilgrastin (PEG-G-CSF) in a phase I study".Chinese Journal of Evidence-Based Medicine 8.3(2008):155-158.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zheng L.]'s Articles
[Xu N.]'s Articles
[Liu C.-T.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zheng L.]'s Articles
[Xu N.]'s Articles
[Liu C.-T.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zheng L.]'s Articles
[Xu N.]'s Articles
[Liu C.-T.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.